Substrate Ablation and Remodelling in Non-paroxysmal Atrial Fibrillation (AF)
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesise that modification of the Atrial Fibrillation (AF) substrate by
radiofrequency ablation would improve single procedure success rates for Radio Frequency
Ablation (RFA) for Non-paroxysmal AF when compared to that achieved with short-term
peri-procedural anti-arrhythmic drug therapy alone.
Phase:
N/A
Details
Lead Sponsor:
Liverpool Heart and Chest Hospital NHS Foundation Trust